KfW — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Acousiaacousia.comMay 2018✓ verified

Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing.

BiotechDigital HealthHealthtechMedical DevicesTübingen, DE

Hubert Löwenheim(Founder / Board Member)

Co-investorsBoehringer Ingelheim Venture Fund Creathor Ventures LBBW Venture Capital GmbH Esperante Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.